Skip to main content

Table 2 Response rates and second line treatments with CT and RT

From: Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer

 

Number of patients

Percentage (%)

Number of PC received

  

   1

2

4

   2

5

10

   3

20

39

   4

3

6

   5

3

6

   6

18

35

Response to PC

  

   PR

23

45

   SD

9

18

   PD

16

31

   Not assessed

3

6

Second line CT

13

 

   G ± Cis / C

10

78

   Other

3

23

Local RT

12

 

   Stage IIIA

3

25

   Stage IIIB

5

42

   Stage IV

4

33

  1. CT: Chemotherapy; RT: Radiotherapy; P: Paclitaxel; C: Carboplatin; G: Gemcitabine; Cis: Cisplatin